Virtual biotech of 37,000 AI agents uncovers promising lung-cancer drug target
burny_tech · x · 2026-09-21
Nature reports on the Virtual Biotech system published in Science: a swarm of up to 37,000 AI agents that autonomously interact with LLMs and each other under a 'chief scientist'. After analyzing thousands of clinical trials, the system surfaced a molecular signal that predicts trial success and, with human oversight, identified an immune-damping protein as a promising lung-cancer drug target — a landmark use of large-scale multi-agent systems in drug discovery.
More from AGI Musings
- Newsweek op-ed: US should fund hospitals and universities in federated AI learning — Saul_Loveman · 2026-11-12
- 10-line deterministic polynomial-time primality test relies on OpenAI's recent quasi-GRH result, making AKS obsolete — fortnow · 2026-11-11
- AI2027 Author Kokotajlo Shifts AGI Median Timeline to Around 2030 — JacquesThibs · 2026-11-11
- Ron Bodkin: automated research taste advances faster than expected, but the evidence is weak — ronbodkin · 2026-11-11
- Should devs still hand-write code? Author proposes 1,000-hour baseline before AI agents — bendee983 · 2026-11-11
- DEF CON panel with Bruce Schneier and Google security VP posted: scaling laws and open weights — JasonDClinton · 2026-11-11